Impact of AR-V7 protein localization in the prediction of therapeutic benefit of taxanes over androgen receptor signaling inhibitors (ARSi) in metastatic castration resistant prostate cancer (mCRPC) Meeting Abstract

  

Authors:	Scher, H.; Graf, R.; Schreiber, N.; Lu, D.; Louw, J.; Alvarez, H. A. V.; Bambury, R.; Danila, D.; McLaughlin, B.; Heller, G.; Fleisher, M.; Dittamore, R.
Abstract Title:	Impact of AR-V7 protein localization in the prediction of therapeutic benefit of taxanes over androgen receptor signaling inhibitors (ARSi) in metastatic castration resistant prostate cancer (mCRPC)
Meeting Title:	41st European Society for Medical Oncology Congress (ESMO)
Journal Title:	Annals of Oncology
Volume:	27
Issue:	Suppl. 6
Meeting Dates:	2016 Oct 7-11
Meeting Location:	Copenhagen, Denmark
ISSN:	0923-7534
Publisher:	Oxford University Press
Date Published:	2016-10-01
Start Page:	vi248
Language:	English
ACCESSION:	WOS:000393912500725
DOI:	10.1093/annonc/mdw372.12
PROVIDER:	wos
Notes:	Meeting Abstract: 728PD -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/109048